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Abstract
Introduction:  The  procedure  used  to  evaluate  salivary  flow  rate  is  called  sialometry.  It  can
be performed  through  several  techniques,  but  none  appears  to  be  really  efficient  for  post-
radiotherapy  patients.
Objective:  To  adequate  sialometry  tests  for  head  and  neck  cancer  patients  submitted  to  radio-
therapy.
Methods: 22  xerostomic  patients  post-radiotherapy  (total  radiation  dose  ranging  from  60  to
70 Gy)  were  included  in  this  study.  Ten  patients  were  evaluated  using  sialometries  originally
proposed by  the  Radiation  Therapy  Oncology  Group  and  twelve  were  assessed  by  our  modi-
fied methods.  Unstimulated  and  stimulated  sialometries  were  performed  and  the  results  were
classified  according  a  grading  scale  and  compared  between  both  groups.
Results:  There  was  no  statistically  significant  difference  between  the  salivary  evaluations  of
both groups  (p  =  0.4487  and  p  =  0.5615).  Also,  most  of  these  rates  were  classified  as  very  low
and low.
Conclusion:  This  novel  method  seems  to  be  suitable  for  patients  submitted  to  radiotherapy.
© 2017  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/).
 Please cite this article as: Palma LF, Gonnelli FA, Marcucci M, Giordani AJ, Dias RS, Segreto RA, et al. A novel method to evaluate salivary
flow rates of head and neck cancer patients after radiotherapy: a pilot study. Braz J Otorhinolaryngol. 2018;84:227--31.
∗ Corresponding author.
E-mail: luizfelipep@hotmail.com (L.F. Palma).
Peer Review under the responsibility of Associac¸ão Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.
https://doi.org/10.1016/j.bjorl.2017.03.004
1808-8694/© 2017 Associac¸a˜o Brasileira de Otorrinolaringologia e Cirurgia Ce´rvico-Facial. Published by Elsevier Editora Ltda. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
228  Palma  LF  et  al.
PALAVRAS-CHAVE
Neoplasias  de  cabec¸a
e pescoc¸o;
Xerostomia;
Radioterapia;
Saliva
Um  novo  método  para  avaliar  as  taxas  de  fluxo  salivar  em  pacientes  com  câncer
de  cabec¸a e  pescoc¸o após  radioterapia:  estudo  piloto
Resumo
Introduc¸ão: O  procedimento  utilizado  para  avaliar  a  taxa  de  fluxo  salivar  é  denominado  sialome-
tria. Pode  ser  realizado  por  meio  de  várias  técnicas,  mas  nenhuma  parece  ser  realmente
eficiente para  pacientes  pós-radioterapia.
Objetivo:  Adaptar  sialometrias  para  pacientes  com  câncer  de  cabec¸a  e  pescoc¸o  submetidos  à
radioterapia.
Método: 22  pacientes  xerostômicos  pós-radioterapia  (dose  de  radiac¸ão  total  variando  de  60-
70 Gy)  foram  incluídos  neste  estudo.  Dez  pacientes  foram  avaliados  utilizando  sialometrias
originalmente  propostas  pelo  Radiation  Therapy  Oncology  Group  e  doze  foram  avaliados  por
nossos métodos  modificados.  Sialometrias  não  estimuladas  e  estimuladas  foram  conduzidas  e
os resultados  foram  classificados  de  acordo  com  uma  escala  de  graduac¸ão  e  comparados  entre
os dois  grupos.
Resultados:  Não  houve  diferenc¸a  estatisticamente  significante  entre  as  avaliac¸ões  salivares  de
ambos os  grupos  (p  =  0,4487  e  p  =  0,5615).  Além  disso,  a  maioria  dessas  taxas  foi  classificada
como muito  baixa  e  baixa.
Conclusão:  Esse  novo  método  parece  ser  adequado  para  pacientes  submetidos  à  radioterapia.
© 2017  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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he  treatment  for  head  and  neck  cancer  (HNC)  is
ased  on  three  therapeutic  modalities:  radiotherapy  (RT),
hemotherapy,  and  surgery.1 The  aim  of  RT  is  to  control
umours  with  the  least  possible  damage  to  adjacent  normal
issues.2 For  most  initial  cases,  RT  as  a  sole  modality  is  con-
idered  the  standard  treatment;  however,  advanced  cases
ust  receive  RT  in  association  with  chemotherapy  and/or
urgery.3
Despite  efforts  on  RT  planning  to  preserve  non-neoplastic
issues  in  tumour  region,  these  are  inevitably  included
nto  the  irradiation  fields  and  suffer  consequences  as
ell.4,5 Intensity  and  extent  of  the  radiation-induced  effects
epends  mainly  on  factors  related  to  treatment  such  as  total
adiation  dose,  radiation  dose  per  fraction,  irradiated  vol-
me,  dose  distribution  in  tissue  volume,  association  with
hemotherapy,2,6 and  its  duration.7
Regarding  HNC  treatment,  the  major  salivary  glands
ften  receive  significant  radiation  doses.8 Although  the
ytotoxic  mechanisms  of  the  radiation  in  salivary  tissue
re  still  not  elucidated,7,9 atrophy  and  acinar  degener-
tion  are  histological  findings  often  encountered.10,11 As
onsequences,  the  subjective  perception  of  dry  mouth  (or
erostomia)  and  the  objective  reduction  in  salivary  flow  rate
SFR)  (or  hyposalivation)  are  common,7,12 dose-dependent,
rreversible  complications.9,13 Additionally,  they  are  almost
lways  accompanied  by  changes  in  the  salivary  characteris-
ics  such  as  pH  values,  immunoglobulin  levels,  electrolyte
alance,  protein  concentrations,  viscosity,  and  colour.8,10,12
It  is  known  that  there  is  no  direct  relationship  between
erostomia  and  low  SFR,  so  efforts  are  needed  to  measure
ach  one  independently.14 In  order  to  assess  xerostomia
n  irradiated  patients,  some  specific  scales  have  been
eveloped.9,13 Likewise,  quality  of  life  questionnaires  have
h
m
Rhe  goal  of  evaluating  xerostomia  in  conjunction  with  other
ell-described  side  effects  of  the  HNC  treatment.13,15 Thus,
ven  subjectively,  an  overview  of  the  patient’s  state  is
chieved.
The  procedure  used  to  assess  objectively  SFR  (sialome-
ry)  is  performed  using  several  techniques,  each  one  having
ts  own  advantages,  disadvantages,  and  challenges.16,17 A
oor  reproducibility16 and  a  number  of  methods  present  in
he  literature,4,6,10,11,13 however,  may  lead  to  inconsistent
esults  and  inappropriate  direct  comparisons.  Furthermore,
here  is  no  reliable,  validated  method  to  evaluate  SFRs  of
NC  patients  submitted  to  RT.
Based  on  the  widespread  97-09  protocol  of  the  Radiation
herapy  Oncology  Group  (RTOG),18 sialometry  tests  were
eveloped  and  applied  in  order  to  carry  out  easy,  rapid,
ccurate  assessments  in  HNC  patients  post-RT.
ethods
atients  and  ethical  considerations
 prospective  study  with  22  patients  was  conducted  in  the
ivision  of  Radiotherapy  of  the  Universidade  Federal  de  São
aulo  (UNIFESP).
All  the  patients  reported  persistent  xerostomia  after
egavoltage  RT  (3D  planning)  for  HNC,  with  radiation  fields
ncompassing  major  salivary  glands  (cervicofacial  regions
nd  supraclavicular  fossae)  and  total  radiation  doses  ran-
ing  from  50  to  70  Gy.  Also,  they  were  aged  ≥18  years  and
ad  received  the  last  RT  session  in  a  period  from  3  to  36
onths  before  the  beginning  of  this  study.
The  present  study  was  approved  by  the
esearch  Ethics  Committee  of  UNIFESP  (protocols
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error  was  0.0296  mL/min.  The  median  of  Test  Group  was
0.1  mL/min  and  the  standard  error  was  0.0307  mL/min.
Concerning  stimulated  sialometries,  the  SFR  of  ControlSialometries  for  head  and  neck  patients  after  radiotherapy  
0844/10-32449414.4.0000.5505)  and  all  research  subjects
read  and  signed  the  informed  consent  form.
Groups  and  general  instructions
The  patients  were  divided  into  two  groups.  Control  Group
consisted  of  10  patients  and  Test  Group  of  12  patients.  Con-
trol  Group  was  assessed  using  the  RTOG’s  97-09  protocol18
and  Test  Group  was  evaluated  by  an  adapted  method  devel-
oped  by  the  authors.
All  patients  were  evaluated  at  the  same  morning  period
by  a  dentist  and  were  advised  to  stay  at  least  2 h  without
eating,  drinking,  smoking,  and  brushing  their  teeth.  Also,
during  saliva  collection  they  remained  seated,  with  their
eyes  opened,  and  heads  slightly  bent  forward.
Modified  sialometry  tests  (saliva  collection)
Unstimulated  sialometry:  just  before  the  saliva  collection,
the  patients  emptied  their  mouths  of  any  saliva  or  mucous.
After  that,  they  accumulated  saliva  on  the  floor  of  the
mouth,  without  swallowing,  for  60  s.  Then,  they  expecto-
rated  the  accumulated  saliva  into  a  tube  graded  in  millilitres
(mL)  with  the  aid  of  a  laboratory  glass  funnel.  It  was
repeated  4  more  times  for  a  total  of  5  min.  Next,  a  metal
spatula  and  2.0  mL  of  distilled  water  were  used  to  remove
the  saliva  adhered  to  the  surface  of  the  funnel.  Also,  0.33  mL
of  simethicone  (75  mg/mL)  was  added  to  the  solution  to
eliminate  gas  bubbles  and  foamy  saliva.  Lastly,  the  tube  was
well  shaken,  the  volume  of  saliva  was  measured,  and  the  SFR
per  minute  could  be  calculated.  Some  materials  are  shown
in  Fig.  1.
Stimulated  sialometry:  firstly,  the  patients  emptied  their
mouths  of  any  saliva  or  mucous.  After  that,  2%  citrate  solu-
tion  was  applied  to  the  dorsolateral  borders  of  the  tongue,
with  a  cotton  tipped  applicator,  5  times  over  2  min  (0,  30,
60,  90,  and  120  s).  Next,  all  the  retained  citrate  solution
in  the  mouth  was  eliminated.  The  steps  of  saliva  collection
and  SFR  assessment  were  the  same  as  for  the  unstimulated
sialometry.
Figure  1  Material.  (A)  Syringe  for  measuring  distilled  water;
(B) simethicone;  (C)  metal  spatula;  (D)  tube  graded  in  millil-
itres; (E)  laboratory  glass  funnel.
G229
ata  analysis
escriptive  analysis  was  used  to  summarize  data  on  the
atients,  tumours,  treatments,  and  sialometries.  In  addi-
ion,  the  unstimulated  and  stimulated  SFRs,  respectively,
ould  be  classified  as:  very  low  (<0.1  and  <0.7  mL/min),
ow  (0.1--0.25  and  0.7--1.0  mL/min),  and  normal  (>0.25  to
1.0  mL/min).17
The  mean  sialometry  values  were  also  submitted  to  the
tudent’s  t-test  for  comparisons  between  both  groups.  The
-value  was  set  at  ≤0.05  to  reach  statistical  significance.
esults
eneral
he  patients’  age  of  Control  Group  ranged  from  37  to  68
ears  (mean  value:  56.3)  and  the  patients’  age  of  Test  Group
anged  from  48  to  73  years  (mean  value:  61.75).  Addi-
ional  demographic  features  of  the  sample  are  summarized
n  Table  1.
Features  of  the  tumours  and  treatments  are  described  in
able  2.
aliva  sampling
he  averages  of  the  unstimulated  and  stimulated  SFRs  are
ummarized  in  Fig.  2  and  their  classifications  in  Table  3.
dditionally,  there  were  no  statistically  significant  differ-
nces  between  both  groups  (p  =  0.4487  and  p  =  0.5615).
Regarding  unstimulated  sialometries,  the  salivary  flow
ates  of  both  groups  ranged  from  0  to  0.3  mL/min.  The
edian  of  Control  Group  was  0.16  mL/min  and  the  standardroup  varied  from  0.04  to  0.5  mL/min,  with  the  median
Table  1  Patients’  demographic  features.
Demographic  features  Control  group  Test  group
Patients  %  Patients  %
Gender
Male  9  90  7  58.3
Female  1  10  5  41.7
Ethnic group
White  7  70  9  75
Black 3  30  3  25
Alcohol  consumption
Non-existent  2  20  0  0
Previous  7  70  8  66.7
Current  1  10  4  33.3
Tobacco  consumption
Non-existent  1  10  0  0
Previous 7  70  10  83.3
Current  2  20  2  16.7
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Table  2  Features  of  the  tumours  and  treatments.
Features  Control  group  Test  group
Patients %  Patients  %
Histological  type  of  the  tumour
Squamous  cell
carcinoma
9  90  12  100
Adenoid  cystic
carcinoma
1  10  0  0
Primary  site  of  the  tumour
Oral  cavity 0  0  2  16.6
Pharynx  8  80  5  41.7
Larynx 2  20  5  41.7
Stage of  the  tumour
I 1  10  2  16.7
II 0  0  1  8.3
III 0  0  1  8.3
IV 9  90  8  66.7
Surgery
Yes 4  40  6  50
No 6  60  6  50
Total radiation  dose
60--69  Gy  3  30  6  50
70 Gy  7  70  6  50
Chemotherapy
Yes 10  100  10  83.3
No 0  0  2  16.7
Stimulated sialometry
Mean salivary flow rates
Unstimulated
sialometry
m
L/
m
in
0.145
0.112
0.264
0.213
0.3
0.25
0.2
0.15
0.1
0.05
0
Control group Test group
Figure  2  Mean  salivary  flow  rates.  The  mean  salivary  flow
rates of  both  groups,  in  millilitres  per  minute  (mL/min).  No
s
p
0
T
w
0
Table  3  Classification  system  of  the  salivary  flow  rates.
Salivary  flow  rate  Control  group  Test  group
Patients  %  Patients  %
Unstimulated
Very  low
(<0.1  mL/min)
3  30  5  41.7
Low
(0.1--0.25  mL/min)
6  60  5  41.7
Normal
(>0.25 mL/min)
1  10  2  16.6
Stimulated
Very low
(<0.7  mL/min)
10  100  11  91.7
Low
(0.7--1.0  mL/min)
0  0  1  8.3
Normal 0  0  0  0
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salivary  secretion.  On  the  other  hand,  mechanical  stimulantstatistically  significant  difference  was  obtained  (p  =  0.4487,
 =  0.5615).
.2750  mL/min  and  the  standard  error  0.0494  mL/min.
he  SFR  of  Test  Group  ranged  from  0  to  0.8  mL/min,
ith  the  median  0.1650  mL/min  and  the  standard  error
.0665  mL/min.
p
t
g(>1 mL/min)
iscussion
ialometries  are  performed  by  drainage,  expectoration,  or
eighing  cotton  wool  balls  soaked  with  saliva.  Some  of
hese  techniques  aim  to  selectively  collect  the  secretion
f  each  salivary  gland,  but  with  little  clinical  applicability
e.g.  catheterization  of  salivary  ducts).  On  the  other  hand,
echniques  which  take  into  account  the  whole  saliva  volume
ollected  over  a  period  of  time  are  the  most  used  since  they
re  faster,  easier,  and  cheaper.16
The  well-known  RTOG’s  protocol  has  been  developed
o  evaluate  the  mitigating  effect  of  pilocarpine  on  hypos-
livation  and  mucositis  in  patients  undergoing  RT.18 So,
rom  our  experience  in  using  this  protocol  for  irradiated
atients  with  no  method  of  prevention  and  treatment  for
yposalivation,19,20 we  considered  necessary  adapting  it  to
ost-RT  patients.  The  unstimulated  sialometry,  in  particular,
ould  be  substantially  improved  by  our  methods,  since  it  is
ased  on  the  collection  of  extremely  small  amount  of  saliva.
During  the  procedures,  the  glass  funnel  facilitated  the
aliva  collection  and  also  prevented  a  possible  volume  loss
ue  to  the  larger  area  for  expectoration.  The  highly  viscous
aliva  that  adhered  to  the  funnel  surface  could  be  easily
emoved  with  the  aid  of  the  metal  spatula  and  distilled
ater.  Another  important  point  was  the  addition  of  sime-
hicone  to  the  solution  to  decrease  the  surface  tension  of
as  bubbles  and  to  disperse  foam.  Thus,  we  could  measure
he  total  saliva  volume  immediately,  avoiding  further  losses
elated  to  the  need  of  leaving  the  saliva  samples  to  rest.
Concerning  the  presence  of  stimulation  in  sialometries,
ustatory  (citric  acid)  and  mechanical  agents  (paraffin,
ilicone,  unflavoured  chewing  gum)  are  used  to  simulate
atients’  conditions  throughout  the  day  (e.g.  eating  and
hewing).  It  is  believed  that  the  absence  of  stimulation
eflects  the  physiological  status  of  the  sublingual  and  sub-
andibular  glands,  as  these  are  responsible  for  baselineromote  marked  response  of  the  parotid  glands  and  gusta-
ory  stimulants  activate  the  three  pairs  of  major  salivary
land  simultaneously.17
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From  our  standpoint,  clinicians  should  carry  out  both
sialometries  for  a  thorough  evaluation  of  irradiated
patients.  For  the  stimulated  sialometry,  the  use  of  2%  citrate
solution  seems  to  be  more  advantageous  because  the  three
pairs  of  major  salivary  glands  (responsible  for  90%  of  saliva
output)  are  evaluated  at  the  same  time.7,12 Also,  edentulous
patients  cannot  be  assessed  using  mechanical  stimulations.
Our  data  showed  the  marked,  persistent,  well-recognised
radiation-induced  reduction  in  SFR.7,9,12,13,19,20 The  lack  of
statistically  significant  difference  between  both  groups  and
the  quite  similar  results  obtained  suggest  that  our  modifica-
tions  in  RTOG’s  protocol  were  satisfactory  and  applicable.
In  general,  the  results  from  the  novel  sialometries  could  be
obtained  more  quickly  than  those  of  RTOG.  Moreover,  our
method  was  easier  than  the  others  and  did  not  require  costly
materials,  factors  really  important  for  the  routine  clinical
use.
Conclusion
This  paper  encourages  further  researches  with  bigger  sam-
ples  to  apply  these  novel  sialometries  in  post-irradiated
patients.  Likewise,  it  would  be  interesting  to  investigate
whether  this  method  is  suitable  for  other  diseases  and  patho-
logical  conditions  which  also  result  in  low  SFR  (e.g.  Sjögren’s
Syndrome).
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